Skip to main content
    P

    Penumbra Inc (PEN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $320.63
    -0.28 (-0.09%)

    Market Cap: $12.65B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Penumbra Inc (PEN) Financials: Revenue, Profit and Cash Flow

    Updated Oct 29, 2026. Financial statements from company filings, amounts in US dollars.

    Penumbra reported revenue of $1.40B for the fiscal year ended Dec 31, 2025, up 17.5% from the year before. That year, net income was $177.69M with a net margin of 12.7%, operating cash flow was $238.66M and free cash flow was $174.93M. The quarter ended Sep 30, 2026 had revenue of $410.14M and net income of $42.28M.

    Revenue and Margins

    The operating margin was 13.5% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $263.32M, a compound annual rate of 20.4%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.40B+17.5%67.1%13.5%12.7%
    Dec 2024$1.19B+12.9%63.2%0.8%1.2%
    Dec 2023$1.06B+25.0%64.5%6.9%8.6%
    Dec 2022$847.13M+13.3%63.2%0.7%-0.2%
    Dec 2021$747.59M+33.4%63.6%-1.0%0.4%
    Dec 2020$560.41M+2.4%60.3%-6.9%-3.4%
    Dec 2019$547.40M+23.0%68.0%8.7%8.6%
    Dec 2018$444.94M+33.3%65.7%-0.2%0.7%
    Dec 2017$333.76M+26.8%65.1%0.3%1.4%
    Dec 2016$263.32MN/A64.9%-0.5%5.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 1168.3% from the year before. In the quarter ended Sep 2026, net income fell 7.8% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$1.40B$1.19B$1.06B$847.13M$747.59M$560.41M$547.40M$444.94M$333.76M$263.32M
    Cost of revenue$461.23M$439.62M$375.88M$311.93M$272.21M$222.24M$175.44M$152.41M$116.62M$92.49M
    Gross profit$942.44M$755.00M$682.64M$535.21M$475.38M$338.18M$371.96M$292.53M$217.14M$170.83M
    Research and development$89.77M$94.78M$102.64M$79.41M$104.55M$90.05M$51.72M$67.00M$31.66M$23.88M
    Operating income$189.25M$9.28M$73.55M$6.08M-$7.50M-$38.94M$47.51M-$852.00K$1.17M-$1.35M
    Net income$177.69M$14.01M$90.95M-$2.00M$2.62M-$19.26M$47.00M$2.91M$4.66M$14.81M
    EBITDA$222.60M$44.57M$106.91M$28.21M$5.91M-$26.39M$55.38M$4.81M$3.60M$102.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$410.14M$390.05M$374.76M$385.38M$354.69M$339.45M$324.14M$315.52M$301.04M$299.40M$278.65M$284.68M
    Gross profit$280.30M$264.94M$253.41M$262.13M$240.42M$224.01M$215.88M$210.72M$200.31M$162.83M$181.14M$186.99M
    Operating income$50.74M$41.04M$38.23M$59.23M$48.84M$40.83M$40.35M$42.77M$35.36M-$80.96M$12.10M$35.03M
    Net income$42.28M$34.81M$32.58M$47.34M$45.85M$45.27M$39.22M$33.68M$29.53M-$60.20M$11.00M$54.22M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $16.23M by $170.66M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.83B$1.53B$1.56B$1.37B$1.24B$822.98M$665.90M$557.86M$476.67M$308.25M
    Current assets$1.22B$951.13M$915.40M$755.70M$681.47M$617.70M$463.13M$410.30M$382.23M$263.83M
    Cash and equivalents$186.90M$324.40M$167.49M$69.86M$59.38M$69.67M$72.78M$67.85M$50.64M$13.24M
    Total liabilities$398.92M$382.25M$377.36M$372.03M$290.32M$185.19M$180.29M$108.33M$76.26M$41.71M
    Short-term debt$16.23M$14.59M$13.43M$11.95M$9.98M$6.03M$8.31M$0$0$0
    Shareholder equity$1.43B$1.15B$1.18B$998.86M$953.93M$641.50M$485.89M$0$400.41M$266.55M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$2.03B$1.97B$1.90B$1.83B$1.74B$1.67B$1.59B$1.53B$1.48B$1.53B$1.58B$1.56B
    Total liabilities$441.59M$443.96M$424.63M$398.92M$385.67M$380.86M$380.43M$382.25M$374.84M$373.33M$376.31M$377.36M
    Cash and equivalents$254.28M$205.27M$241.29M$186.90M$321.03M$421.77M$376.05M$324.40M$280.48M$288.33M$223.11M$167.49M
    Shareholder equity$1.58B$1.53B$1.47B$1.43B$1.36B$1.29B$1.21B$1.15B$1.10B$1.16B$1.20B$1.18B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 73.3% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$238.66M$168.48M$97.33M-$55.66M$9.50M-$33.24M$26.65M$28.81M$12.69M-$12.81M
    Capital expenditures$63.73M$21.18M$15.21M$19.30M$21.18M$24.76M$22.11M$9.60M$12.53M$13.63M
    Free cash flow$174.93M$147.30M$82.12M-$74.96M-$11.68M-$58.00M$4.54M$19.20M$159.00K-$26.44M
    Dividends paidN/AN/AN/A$8.04M$15.83M$683.00K$1.76M$4.48M$0$0
    Share repurchases$0$100.39M$0$0N/AN/AN/AN/AN/AN/A
    Investing cash flow-$404.59M$77.62M-$16.08M$54.79M-$21.73M-$104.15M-$12.71M-$385.00K-$77.65M$687.00K
    Financing cash flow$26.53M-$87.01M$16.20M$11.62M$836.00K$134.92M-$8.96M-$9.81M$104.36M$7.13M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$41.51M$46.08M$86.97M$86.48M$58.26M$44.95M$48.97M$51.11M$56.47M$22.61M$38.30M$36.26M
    Capital expenditures$15.11M$13.54M$13.67M$18.43M$16.25M$15.58M$13.47M$5.37M$5.45M$4.54M$5.82M$3.65M
    Free cash flow$26.40M$32.54M$73.30M$68.05M$42.01M$29.37M$35.50M$45.74M$51.02M$18.07M$32.47M$32.62M
    Last 12 quarters

    Frequently Asked Questions About PEN

    What is Penumbra's annual revenue?

    Penumbra reported revenue of $1.40B for the fiscal year ended Dec 31, 2025.

    How fast is Penumbra's revenue growing?

    Revenue was up 17.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 18.3%.

    Is Penumbra profitable?

    Yes. Penumbra reported net income of $177.69M for the fiscal year ended Dec 31, 2025, with a net margin of 12.7%.

    How much free cash flow does PEN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $238.66M minus capital expenditures of $63.73M produced free cash flow of $174.93M.

    How much debt does Penumbra have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $16.23M and cash and equivalents of $186.90M.